Halozyme Therapeutics
HALO
#1865
Rank
S$14.15 B
Marketcap
S$124.12
Share price
0.30%
Change (1 day)
35.01%
Change (1 year)

EPS for Halozyme Therapeutics (HALO)

EPS in 2026 (TTM): S$4.55

According to Halozyme Therapeutics's latest financial reports the company's current EPS (TTM) is S$4.54. In 2025 the company made an earnings per share (EPS) of S$3.37 a decrease over its 2024 EPS that were of S$4.51.

EPS history for Halozyme Therapeutics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$4.5535.18%
2025S$3.37-25.43%
2024S$4.51
2022S$1.91-48.07%
2021S$3.67196.87%
2020S$1.24-292%
2019S-$0.64-9.09%
2018S-$0.71-237.5%
2017S$0.52-149.38%
2016S-$1.04211.54%
2015S-$0.34-52.73%
2014S-$0.71-24.66%
2013S-$0.9448.98%
2012S-$0.63

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$8.61 89.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$0.92-79.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$39.83 777.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$2.55-43.73%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
S-$1.82-140.06%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
S-$0.17-103.69%๐Ÿ‡บ๐Ÿ‡ธ USA